Singapore is poised to emerge as a critical supplier and processing node for semiconductors that can handle the vast computing and memory needs of running generative artificial intelligence (gen AI) applications on devices as compact as smartphones.
products As the global market for gen AI encompassing both hardware and software enters a widely expected boom over the next few years, chipmakers here in Singapore and elsewhere are looking to increase their production capacity and broaden their talent pool.
Many chipmakers are in the race, including Qualcomm, which has a test centre of excellence in Singapore that carries out design verification and failure analysis for the smartphone chipmaker's products and technologies.
new But the company that gives Singapore the largest footprint in the gen AI chip market is Micron Technology one of the world's top producers of memory chips that process and store data.
Because of Micron, Singapore commands a 10 per cent share in the high-end global memory market, according to HSBC.
And demand for these memory chips is set to increase as exponentially as that of logic chips, which perform computing functions.
Mr Sumit Sadana, executive vice-president and chief business officer at Micron, believes that 2024 will be the first year when personal computers armed with AI devices and applications will start getting introduced. Some latest smartphones with AI capabilities are already in the market.
Production of these devices will then ramp up quite heavily in 2025 and 2026, he said.
But this period will eventually be seen as just the beginning of a much longer investment and innovation cycle.
"It is really in its early infancy of what will be a 10- and 20-year wave of investment that will drive AI into every corner of the economy and every part of the lives of consumers," he told The Straits Times in an interview.
この記事は The Straits Times の April 26, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は The Straits Times の April 26, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
THE NEW BERNABEU A REAL PROBLEM
Locals and neighbourhood residents hate noise from concerts and construction work
Japan seek to beat the heat and Saudi Arabia
HONG KONG - Japan face second-placed Saudi Arabia in Group C of Asia's third round of World Cup qualifiers in Jeddah on Oct 10, looking to continue their prolific start as top-of-the-table clashes take centre stage across the continent.
Police investigating Spanish pair over protests in S'pore
A Spanish man and woman in their 30s are assisting the police with investigations after photos appeared on social media of the man holding a banner in various parts of Singapore to protest against Singaporean business magnate Peter Lim, who owns Spanish top-tier football club Valencia.
FROM SAUDI SPLURGE TO SPENDING SLUMP
Football transfer outlay drops in 2024 as officials assess the commercial returns
Future looks bright for America's Cup: Ainslie
BARCELONA - Sailing has a great opportunity to develop as a sport if the America's Cup can involve more frequent events and evolve the boats now being raced, according to British skipper Ben Ainslie.
Sport can be 'solution multiplier' for climate
LONDON – Sports clubs and organisations must raise their game and become leaders in the battle to prevent catastrophic climate change, Sport England chairman Chris Boardman said on Oct 8.
SINNER TO BE GIVEN NO QUARTER
Medvedev vows to put up a better fight against world No. 1 in Shanghai last eight
Ryder Cup captains won't exclude LIV Golf players
NEW YORK - Ryder Cup captains Keegan Bradley and Luke Donald said on Oct 8 that they will not shy away from including LIV Golf players in their respective teams for the 2025 biennial showdown between the United States and Europe.
MISTY SWIFT EARNS EVEN MORE FANS AT TRIALS
Ex-Kranji runner No More Delay also struts his stuff at hit-outs
MediShield Life can be made more effective. Its review holds the key
We must incentivise outpatient treatment and accept that, in some cases, personalised medicine can save lives.